Here are the top health stories for the day:
Should the 2019 MBBS batch give the NExT exam? Doctors point out violations of the NMC act
MBBS Students and doctors have opposed the recent Gazette notification regarding the "NMC, National Exit Test Regulations, 2023" specifying the mode and manner of conducting the common exit test cum licentiate examination i.e. NExT.
While the National Medical Commission (NMC) has confirmed that MBBS batch of 2019 will be the first to appear in the National Exit Test (NExT) examination next year, several doctors have pointed out that implementing NExT exam for the 2019 batch is actually a violation of the NMC Act 2019.
On the one hand, the students have pointed out that there is no clarity regarding the schedule for the NExT exam, on the other, they have strongly opposed the decision to hold the examination at such short notice.
For more details, check out the link given below:
Should 2019 MBBS Batch Give NExT Exam? Doctors Point Out Violations Of NMC Act
No bail for the doctor who rammed his car inside the hospital in a drunken state leading to the death of one patient, miscarriage of another
Denying relief to a doctor, who allegedly caused the spot death of one person and the miscarriage of a pregnant woman as a result of his drunk driving at the hospital premises, the Rajasthan High Court has rejected his bail application.
Rejecting the bail plea, the High Court bench of Justice Kuldeep Mathur observed, "In the prima facie opinion of this Court, the incidents of speeding and drunken driving are increasing day by day and are the major contributing factors in the road accidents. While granting bails in such matter, the seriousness of the accusations has to be taken into consideration. The cases of such nature just cannot be compared with the cases where a person causes death by rash or negligent driving."
For more details, check out the link given below:
A nation has approved use of psychedelics for treating depression
Australia becomes the first country where psychiatrists can prescribe certain psychedelic substances to patients with post-traumatic stress disorder or depression.
NPPA fixes retail price of 51 formulations, details
Through a recent notification, the National Pharmaceutical Pricing Authority (NPPA) has fixed the retail prices of the 51 formulations including those used to treat type 2 diabetes, bacterial infections, and others.
This came in line with the decision of the 114th Authority meeting dated 19.06.2023, where the authority discussed the new drug applications for price fixation under para 5 and 15 of DPCO 2013.
These include Skymap Healthcare & Healing Pharma's Ciprofloxacin & Dexamethasone Eye Drops, Cris Pharma& Mankind Prime Lab's Paracetamol, Phenylephrine and Chlorpheniramine Drops, Akums Drugs & Eris Life science's Paroxetine Controlled release & Clonazepam Capsules.
For more details, check out the link given below:
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.